Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Track income, expenses, savings, and debt payments to gain a clear view of your financial health and progress.
16,473 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Binance founder Changpeng Zhao addresses social media chatter claiming a Dubai surfing accident, calling the reports ...
Security researchers warn that the next DeFi exploit will likely begin in the developer supply chain, exploiting pack...
Imagine Micron topping a trillion-dollar market cap. The market would react in unpredictable ways. This guide explain...
Citigroup reports decade-high revenue in a pivotal year for Citi’s 5-year comeback: jane, highlighting a broad-based ...
Investors are watching Micron’s rally with curiosity. This guide explains why micron stock keeps going, what drives t...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
Berkshire Hathaway underperforming vs the S&P 500 in 2026, even as Warren Buffett’s top holdings rise. A look at why ...
Investors are buzzing about a possible SpaceX-Tesla merger. This guide explains the real possibilities, benefits, ris...
When a respected lab equipment company posts solid results, investors often respond with enthusiasm. This article unp...
CoStar Group has agreed to acquire Bora Inc., the parent of Zonda, from MidOcean Partners for $800 million in cash, a...
As TD prepares for its Q2 2026 report, investors weigh margin trends, loan growth, and capital returns. This guide br...